These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 25366329)
1. Canada's new law strengthens drug regulatory powers but is vague on mandatory trial registration. Dyer O BMJ; 2014 Nov; 349():g6620. PubMed ID: 25366329 [No Abstract] [Full Text] [Related]
2. Warning label limbo. FDA rule letting generic-drug makers update risk alerts draws heavy flak. Carlson J Mod Healthc; 2014 Jun; 44(26):20-2. PubMed ID: 25134408 [No Abstract] [Full Text] [Related]
3. Silence is not the best medicine: requiring disclosure of clinical trial data for abandoned drugs. Powell B J Leg Med; 2012 Oct; 33(4):571-92. PubMed ID: 23216153 [No Abstract] [Full Text] [Related]
4. Canadian health ministry is given new powers to tighten drug safety. Dyer O BMJ; 2014 Jun; 348():g4231. PubMed ID: 24962373 [No Abstract] [Full Text] [Related]
5. Clinical trial transparency--antidote to weaker off-label-promotion rules? Outterson K N Engl J Med; 2014 Jul; 371(1):1-3. PubMed ID: 24988551 [No Abstract] [Full Text] [Related]
6. Unlocking Health Canada's cache of trade secrets: mandatory disclosure of clinical trial results. Herder M CMAJ; 2012 Feb; 184(2):194-9. PubMed ID: 21876028 [No Abstract] [Full Text] [Related]
7. The US requirement to deposit trial data within a year is unworkable. Meinert CL BMJ; 2013 Nov; 347():f6449. PubMed ID: 24185131 [No Abstract] [Full Text] [Related]
8. Europe drug regulator wins appeal over release of trial data. Kmietowicz Z BMJ; 2013 Dec; 347():f7341. PubMed ID: 24319261 [No Abstract] [Full Text] [Related]
9. Drug information not regulation is needed. Anderson IM J Psychopharmacol; 2004 Mar; 18(1):14-5; author reply 18-9. PubMed ID: 15107177 [No Abstract] [Full Text] [Related]
10. Health Canada's new clinical trials database should be mandatory, says expert. Shuchman M CMAJ; 2013 Aug; 185(11):946. PubMed ID: 23798458 [No Abstract] [Full Text] [Related]
12. Bringing the FDA's Information to Market. Woloshin S; Schwartz LM Arch Intern Med; 2009 Nov; 169(21):1985-7. PubMed ID: 19933960 [No Abstract] [Full Text] [Related]
13. Clinical trial data: to disclose or not to disclose? Bouchie A Nat Biotechnol; 2006 Sep; 24(9):1058-60. PubMed ID: 16964203 [No Abstract] [Full Text] [Related]
14. Making information about clinical trials publicly available. Smyth RL BMJ; 2009 Jun; 338():b2473. PubMed ID: 19556275 [No Abstract] [Full Text] [Related]
15. European Commission orders France to lift ban on acne pill. Arie S BMJ; 2013 Aug; 347():f4932. PubMed ID: 23918671 [No Abstract] [Full Text] [Related]
16. [Direct reporting by patients of adverse drug reactions in Spain]. Esther Salgueiro M; Jimeno FJ; Aguirre C; García M; Ordóñez L; Manso G Farm Hosp; 2013; 37(1):65-71. PubMed ID: 23461502 [TBL] [Abstract][Full Text] [Related]
20. North American regulatory agencies can and should make clinical trial data publicly available. Persaud N; Doshi P CMAJ; 2016 Feb; 188(2):96-97. PubMed ID: 26464136 [No Abstract] [Full Text] [Related] [Next] [New Search]